Cargando…
Carnitine palmitoyl transferase-1A (CPT1A): a new tumor specific target in human breast cancer
Transcriptional mechanisms epigenetically-regulated in tumoral tissues point out new targets for anti-cancer therapies. Carnitine palmitoyl transferase I (CPT1) is the rate-limiting enzyme in the transport of long-chain fatty acids for β-oxidation. Here we identified the tumor specific nuclear CPT1A...
Autores principales: | Pucci, Sabina, Zonetti, Maria Josè, Fisco, Tommaso, Polidoro, Chiara, Bocchinfuso, Gianfranco, Palleschi, Antonio, Novelli, Giuseppe, Spagnoli, Luigi G., Mazzarelli, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991433/ https://www.ncbi.nlm.nih.gov/pubmed/26799588 http://dx.doi.org/10.18632/oncotarget.6964 |
Ejemplares similares
-
CX3CR1 Receptor Polymorphisms, Th1 Cell Recruitment, and Acute Myocardial Infarction Outcome: Looking for a Link
por: Pucci, S., et al.
Publicado: (2013) -
Fenofibrate Therapy in Carnitine Palmitoyl Transferase Type 2 Deficiency
por: Hamilton-Craig, I., et al.
Publicado: (2012) -
Bone scinitigraphy in rhabdomyolysis associated with carnitine palmitoyl transferase deficiency
por: Wong, Jonathan, et al.
Publicado: (2010) -
Nutrition and Exercise in a Case of Carnitine Palmitoyl-Transferase II Deficiency
por: Parimbelli, Mauro, et al.
Publicado: (2021) -
Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer
por: Tan, Zheqiong, et al.
Publicado: (2021)